2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)aceticacid
CAS: 220991-20-8
Rif. IN-DA00709G
| 10mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione | ||
| 250mg | Fuori produzione |
Informazioni sul prodotto
Nome:
2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)aceticacid
Sinonimi:
- [u'COX 189', u'COX-189', u'lumiracoxib', u'prexige', u'Lumiracoxib', u'220991-20-8', u'Prexige', u'COX-189', u'COX 189', u'Lumaricoxib', u'COX189', u'UNII-V91T9204HU', u'CHEMBL404108', u'2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid', u'CHEBI:73044', u'{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid', u'V91T9204HU', u'NCGC00181795-01', u'2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid', u'Joicela', u'2-((2-Chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid', u'DSSTox_CID_28961', u'DSSTox_RID_83226', u'DSSTox_GSID_49035', u'2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)acetic acid', u'Benzeneacetic acid, 2-((2-chloro-6-fluorophenyl)amino)-5-methyl-', u'Prexige (Novartis)', u'CAS-220991-20-8', u'Lumiracoxib (USAN/INN)', u'Lumiracoxib [USAN:INN]', u'lumiracoxibum', u'2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid', u'2-[2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid', u'2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid', u'Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-5-methyl-', u'4llz', u'4oty', u'LUR', u'Prexige, Lumiracoxib', u'lumiracoxib-cox-189', u'Lumiracoxib (COX-189)', u'AC1L45SO', u'SCHEMBL4479', u'MLS003882594', u'Lumiracoxib [USAN:INN:BAN]', u'GTPL2897', u'ZINC7563', u'DTXSID9049035', u'CTK8D3900', u'KS-00000XKD', u'HMS3264F19', u'HMS3651H08', u'BCP06134', u'Tox21_113566', u'BDBM50207446', u'CGS-35189', u's2903', u'STL239146', u'AKOS015895138', u'Tox21_113566_1', u'AC-1738', u'API0003229', u'CCG-213068', u'DB01283', u'KS-1302', u'MCULE-3735047846', u'RTC-030184', u'SB19319', u'NCGC00181795-02', u'NCGC00181795-03', u'AN-14665', u'CC-30085', u'SC-19541', u'SMR002529582', u'AB0018348', u'LS-185762', u'LS-187022', u'LS-187647', u'TC-030184', u'AK00536057', u'FT-0601568', u'SW219769-1', u'D03714', u'AB01563279_01', u'991L208', u'A815920', u'C-18422', u'SR-01000930684', u'I06-0368', u'J-014493', u'SR-01000930684-2', u'2-[2-(2-chloro-6-fluoro-anilino)-5-methyl-phenyl]acetic acid', u'2-[2-[(2-chloranyl-6-fluoranyl-phenyl)amino]-5-methyl-phenyl]ethanoic acid', u'Prexige (TN)', u'C15H13ClFNO2', u'D04YMH', u'Novartis brand of lumiracoxib', u'CID151166', u'R809', u'B1458', u'C473384', u'2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid']
- COX 189
- {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid
- 2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetic acid
- Prexige
- Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-5-methyl-
- Lumiracoxib
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
293.7206
Formula:
C15H13ClFNO2
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)
InChI key:
KHPKQFYUPIUARC-UHFFFAOYSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
